Veranova

Veranova's Senior Process Engineer, Dr. Ankur Kapil (PhD, CEng, MIChemE), explored the importance of implementing a rigorous mixing methodology during scale-up in this Expert Insights. At Veranova, we apply our extensive expertise to ensure that multiphase reactions are scaled up safely and reliably. Read the full article here: https://lnkd.in/eUW52ge6

As leaders in solid form and particle engineering, Veranova is proud to offer expertise and a comprehensive suite of techniques for #API separation, isolation, and processing. In particular, we excel in #SprayDrying and can provide our customers with capabilities to handle 500 mg to multiple kilo-scale capacities. Veranova also provides robust characterization, analysis, and facilities to handle spray drying for #HPAPIs and controlled substances. Check out our spray drying video to learn more:

#DYK Veranova has experience in the development and production of #PEGylated molecules and synthetic lipids? Alongside our comprehensive expertise in #ADCs and other drug-conjugate polymers, we can also provide unique stabilization and purification techniques to improve efficiency, cost, and quality for flexible molecule production. Visit our new PEGs and lipids webpage to learn more: https://lnkd.in/dJNAA6du

Next week, the Veranova team will head to Parsippany, NJ, to attend the annual ChemOutsourcing Week event. If you’re attending, be sure to catch our expert, Dom Hebrault, Ph.D., Associate Director, Crystallization Development & Solid Form Science, on 5th September where he will be speaking on the "Flow Chemistry: Advances and Challenges" panel at 4 PM (EST). To learn more or book a meeting, get in touch: https://lnkd.in/gqDcGEPT

#DYK the first antibody-drug conjugate (#ADC) was approved by FDA in 2000, yet the second new approval wasn't until 2011? In recent years, there has been a significant increase in the demand for ADCs. In our white paper: The ABC of ADCs: Fundamentals of Technical, Regulatory, and Clinical Insights, Veranova's Global Vice President, Analytical R&D, Kishore Hotha, PhD, MBA, explores everything you need to know about ADCs today. Download now: https://lnkd.in/e-YmynGb

This week, Veranova's Craig Grant, Global Director, Solid Form and Particle Engineering, and Nelson Down-Jones, Business Development Manager, are attending American Chemical Society's #ACSFall2024 conference. Check out Craig's talk today at the AGRO symposium entitled "Solid Form Science in #Agrochemical and #Pharmaceutical Industries – Opportunities and Challenges."

Will you be in Boston, MA, this week for World ADC Event Series' 2nd #ADC Linker & Conjugation Summit? If you are, make sure to catch the Veranova team and learn more about how we can support you and help overcome your complex #AntibodyDrugConjugate projects through collaboration: https://lnkd.in/eQWiftp7

Veranova will be attending American Chemical Society's #ACSFall2024 conference next week. If you'll also be in attendance, make sure to join our Global Director, Solid Form and Particle Engineering, Craig Grant, at the AGRO symposium. His talk, "Solid Form Science in #Agrochemical and #Pharmaceutical Industries – Opportunities and Challenges," will delve into crucial insights on solid state forms and their impact on product development.

Veranova continues to strengthen its position as a global #CDMO by appointing Mayya Buffington as Vice President, Chief Information Officer. Bringing over two decades of experience in the life sciences industry, and 12 years of expertise in global IT leadership, in Mayya will be an integral part of advancing Veranova's IT suite. Read more about her background and appointment: https://lnkd.in/dB6qj3Kt

Stability and compatibility are vital factors to consider in the development of all therapeutics. For anti-retroviral medicines, which are vital for patients with HIV and AIDS, ensuring the long-term stability of the API is crucial to protect those living with HIV and those at increased risk. In this #LinkedIn article, Veranova demonstrates its expertise in stability studies through this case study on the development of an anti-retroviral contraceptive recommended by World Health Organization (WHO). Read now: